FDA Approves Foundayo (Orforglipron): The First Unrestricted Oral GLP-1 for Weight Loss

A New Era in Obesity Medicine: No Needles, No Fasting For years, people living with obesity have relied on injectable GLP-1 receptor agonists for effective medical weight management. While these treatments are highly effective, the requirement for weekly injections can…




